CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $25.5 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of 80 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.

The gene therapy company posted revenue of $2.6 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $3 million.

Voyager Therapeutics shares have climbed 22 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $20.18, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR